Harvey CJ, Thimmulappa RK, Sethi S, Kong X, Yarmus L, Brown RH, et al
one study found a 40 percent reduction in antibodies in people with Hashimotos, with three to six months of therapeutic doses of selenium
However, it affects different receptors
Once inside the cell, the complex interacts with intracellular copper-responsive pathways which is what enables the downstream gene-modulation effects to translate from topical application into measurable dermal changes
Whether youre focused on anti-aging, post-procedure recovery, or scar reduction, our approach supports long-term results with clinical backing